The Royal College of Physicians and Surgeons of Canada: Applying competency-based practices to residency education.
To contribute to the success of Canadian physicians and the delivery of high-quality patient care, the Royal College of Physicians and Surgeons of Canada has embarked upon an initiative to introduce competency-based medical education (CBME) in Canadian postgraduate specialty training and in professional practice in Canada. This initiative, called Competence by Design (CBD), aims to enhance patient care by aligning medical education and lifelong learning with evolving patient needs and empowering learners to more fully engage in their education process.
CBD will use time as a framework rather than the basis for progression. It is not anticipated that the duration of training will change for the majority of trainees. Residency programs will be broken down into stages, and each stage will have a series of milestones based on required competencies. These milestones will create more targeted learning outcomes and involve more frequent, formative assessments within the clinical workplace to ensure residents are developing and receiving feedback on the skills they need.
Hematological Pathology programs in Canada will adopt CBD in July 2022. Thus residents entering Hematological Pathology will experience CBD-based learning and assessment. As the adoption of this model is refined it will be enhanced to better reflect stakeholder needs.
All programs implementing CBD will continue to undergo the same rigorous accreditation processes as traditional programs. All CBD programs (and traditional programs) will continue to lead to Royal College approved certification. Certification for trainees in both CBD and traditional programs will include the completion of a Royal College examination; however, residents in CBD programs will also be assessed against program milestones throughout their training. Within a CBD program, all milestones (documented within an electronic portfolio) and the Royal College examination must be successfully completed to achieve certification.
Program application language: English
Thank you for your interest in the Postgraduate Education program in the Department of Hematological Pathology at The University of Toronto. This is the one of the largest Hematological Pathology residency programs in Canada in number of teaching staff, research productivity, hospital facilities and patient volume. (The University of Toronto is the tertiary referral centre for a metropolitan population of more than 2,600,000 and a surrounding population of about 6,000,000) These resources offer an unequalled opportunity for Hematological Pathology residency training. The very large research establishment and strong academic program provide a supportive environment for learning and enquiry in all aspects of Hematological Pathology.
Our program seeks to equip trainees to be the pathology leaders of the future. Accordingly, we are looking for a cohort of residents that are committed to a career in pathology, keen to advance the evolving role of pathology in patient care and are capable of learning, understanding and integrating the large volume of material required.
The University of Toronto offers a comprehensive program in Hematological Pathology, which is accredited by the Royal College of Physicians and Surgeons of Canada. Over 20 staff hematological pathologists at multiple sites are involved in resident education. These sites include: The Hospital for Sick Children, Mount Sinai Hospital, St. Michael's Hospital, Sunnybrook Health Sciences Centre, Michael Garron Hospital, The University Health Network, Trillium Health Partners, LifeLabs and St. Joseph’s Health Centre. Each of these sites has particular strengths and allows the program as a whole to offer residents experience in all areas of Hematological Pathology practice.
Visit our website at http://www.lmp.utoronto.ca/postgraduate/residency-training-programs
Proof of valid current citizenship or permanent resident status must be provided by submitting one of the following verifications to CaRMS by the File Review Opening deadline. Failure to provide valid proof will result in your application being removed. No other forms of verification are acceptable:
CaRMS is partnering with third-party organizations to automate the verification of citizenship/legal status required by postgraduate offices for entry into residency. Third-party verification simplifies the process for applicants and programs. All applicants who do not receive third-party citizenship verification will be required to upload and assign an acceptable proof of citizenship document. Please see additional information here.
Three references from teaching or attending staff are required.
Order from your Dean's Office.Medical School Transcript
Order from your RegistrarPersonal Letter
Please outline any personal history that may be relevant to your application. Also state your reasons for choosing Hematological Pathology as a career and outline your academic and non-academic accomplishments, as well as future goals.
Maximum word count: 1000 (no minimum)Photo
If applicant is successful, ACLS is required before commencement of PGY1 clinical rotations. Please visit the PGME website for information on courses available through the University of Toronto.MCCQE Part I - Statement of Results
Applications submitted after file review has opened on January 31, 2022
Supporting documents (excluding letters of reference) that arrive after file review has opened on January 31, 2022
Letters of reference that arrive after the unmasking date on January 31, 2022
Due to the high volume of applications we will NOT consider applications, reference letters or other supporting documents submitted after the file review has opened.
Applicants providing evidence of high academic achievement, a demonstrated commitment to hematological pathology in particular, and evidence of research or similar academic potential in the CaRMS application file will be prioritized for further consideration. Successful applicants will be able to further elaborate their achievements at the time of interviews.
Upon completion of training, a resident is expected to be a competent specialist in Hematological Pathology capable of assuming a consultant’s role in the specialty. The resident must acquire a working knowledge of the theoretical basis of the specialty, including its foundations in science and research, as it applies to medical practice. The intent of a Hematological Pathology training program is to ensure that specialists in Hematological Pathology have the competence to act as consultants to clinicians with respect to appropriate investigation, diagnosis and monitoring of disorders of the blood cells, bone marrow, lymph nodes, spleen, and hemostasis. The resident is expected to be competent in all aspects of organizing and running a transfusion medicine service as well as to be competent in laboratory management issues of blood and blood product procurement and issuing. The resident will have a broad experience in both clinical and laboratory practice. The resident will understand the needs of laboratory Hematology in an adult, pediatric and community setting.
Applicants providing evidence of high academic achievement, a demonstrated commitment to hematological pathology and evidence of research or similar academic potential in the CaRMS application file will be prioritized for further consideration. Successful applicants will be able to further elaborate their achievements at the time of interviews.
Candidates who fail to meet the level of academic achievement required or evidence of commitment to a career in hematological pathology will not be considered further. Other candidates will be ranked based on the scores of their application (50%) and interview (40%) and general fit with the program (10%). Final ranks will be determined solely by the aggregate score as outlined above.
Review team composition : Our review team is composed of the program director, site directors, senior hematological pathology resident and designated faculty members.
Average number of applications received by our program in the last five years : 51 - 200
Average percentage of applicants offered interviews : 0 - 25 %
|CV||We evaluate all content including research, publications, volunteer activities and interests|
|Electives||We recognize that the COVID-19 pandemic has impacted candidates’ opportunities to arrange and complete electives and would like to reassure you that a lack of elective activity this year will not negatively impact your application to our program.|
|Examinations||We evaluate all examination results.|
|Extra-curricular||We evaluate all activities including mentoring and volunteer activities|
|Leadership skills||We evaluate leadership positions and programs that develop leadership skills|
|MSPRs||We evaluate all past performance including undergraduate and graduate studies.|
|Personal letters||We evaluate interest in, and dedication to, hematological pathology and our program.|
|Reference documents||We evaluate all reference letters for evidence of excellence in CanMEDS roles.|
|Research/Publications||We evaluate participation in, and dedication to, research activties including publications.|
|Transcripts||We evaluate all academic performance.|
Interview format :
We routinely accommodate requests to re-schedule interviews for applicants.
|Collaboration skills||We evaluate the ability to work in a team environment to provide exemplary care.|
|Collegiality||We evaluate behaviour, attitudes and professionalism as demonstrated by the candidate.|
|Communication skills||We evaluate proficiency in effective written and spoken English within a team environment|
|Health advocacy||We evaluate dedication to health advocacy.|
|Interest in the discipline||We evaluate interest & dedication to the knowledge and skills required to practice HP|
|Interest in the program||We evaluate interest and commitment to our Hematological Pathology Residency Training Program|
|Leadership skills||We evaluate a commitment to developing leadership skills required for a hematopathology practice.|
|Professionalism||We evaluate the ability to demonstrate professional conduct at all times.|
|Scholarly activities||We evaluate all scholarly activity including research and teaching|
|Other interview component(s)|
This residency program is for 4 years.
Program length of training does not exceed the Royal College or College of Family Physicians of Canada standard.
Hematological Pathology is a four year program. The four year program is structured to meet the requirements of the Royal College of Physicians and Surgeons of Canada.
Starting in July, 2022, all PGY1 residents in Hematological Pathology residency training programs throughout Canada will implement a Competence By Design (CBD) curriculum format. This is a Competency Based Medical Education system instituted by the Royal College of Physicians and Surgeons of Canada. CBD will mainly reflect changes in the way residents are coached, assessed and promoted throughout their residency. Under CBD, the residency is divided into four stages: Transition to Discipline, Foundations of Discipline, Core of Discipline, and Transition to Practice
The first stage for residents is Transition to Discipline (TTD), which will include an orientation Hematological Pathology.
Foundations of Discipline (FOD), the second stage of the continuum of residency education, is when the basics are taught, learned, assessed, and demonstrated.
Core of Discipline (COD) is the third stage of the continuum of residency education and is the longest stage of training. During this stage, the resident will complete various Hematological Pathology rotations to gain competence in the diagnosis and monitoring of disorders of blood cells, bone marrow, lymph nodes, spleen and hemostasis. It is anticipated that in the future the specialty exam will be administered near the end of the Core stage.
The fourth and final stage of residency education is Transition to Practice (TTP), which focuses on ensuring residents’ confidence and competence to practice within their discipline. This stage occurs after the completion of the RC exams to allow the resident some flexibility to complete research projects and rotations of particular interest.
Hematological Pathology Research
The resident will be expected to undertake a research project under the supervision of a faculty member. The research project can be at the basic science or clinical laboratory level. There are extensive opportunities for research within the department.
Seminars and an organized teaching program supplement residency training. Centralized and hospital-based seminars and rounds are held regularly, as well as graduate and joint interdepartmental seminars which residents are encouraged to attend. An academic half-day each week is an integral part of the program.
Since July 1, 2008 all University of Toronto Residents entering PGY1 are required to complete the web based PGCorEd* core competency modules as part of their residency program certification. These modules provide the foundation for non-clinical roles for the RCPSC and CFPC Programs. These modules are focused for PGY 1 & PGY2 trainees. Failure to complete the modules will delay processing of Final In-Training Evaluation Reports (FITERs) and may constitute professional misconduct.
The university division of Hematopathology has staff and facilities at Mount Sinai Hospital, Sunnybrook Health Sciences Centre, The University Health Network, The Hospital for Sick Children, Unity Health, Michael Garron Hospital, LifeLabs and Trillium Health Partners. The training program, however, operates as a single unit. The facilities provided in the four major teaching hospitals are extensive. The volume in the combined hospitals is larger than any other centre in Canada. In all these hospitals the entire spectrum of hematological pathology is available for resident teaching. There is a wide array of different instrumentation and technology used so the resident has exposure to a range of procedures.
|SUMMARY ID||Section||Summary of changes||Updated on||NOTIFY APPLICANTS||SECTION NAME||Actions|